United States
Germany
Japan
United Kingdom
China
CAMTA1 (NM_001195563) Human Tagged ORF Clone Lentiviral Particle
CAT＃: RC230925L3V
- LentiORF®
-
Lenti ORF particles, CAMTA1 (Myc-DDK-tagged)-Human calmodulin binding transcription activator 1 (CAMTA1), transcript variant 2, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 7,410.00
货期*
详询
规格
Product images
经常一起买 (3)
Specifications
| Product Data | |
| Product Name | CAMTA1 (NM_001195563) Human Tagged ORF Clone Lentiviral Particle |
| Synonyms | CANPMR |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| ACCN | NM_001195563 |
| ORF Size | 240 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(RC230925).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_001195563.1 |
| RefSeq ORF | 243 bp |
| Locus ID | 23261 |
| Protein Families | Transcription Factors |
| MW | 9.6 kDa |
| Gene Summary | The protein encoded by this gene contains a CG1 DNA-binding domain, a transcription factor immunoglobulin domain, ankyrin repeats, and calmodulin-binding IQ motifs. The encoded protein is thought to be a transcription factor and may be a tumor suppressor. However, a translocation event is sometimes observed between this gene and the WWTR1 gene, with the resulting WWTR1-CAMTA1 oncoprotein leading to epithelioid hemangioendothelioma, a malignant vascular cancer. [provided by RefSeq, Mar 2017] |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
You may also need
Customer
Reviews
Loading...
